ArticleFrontiers in oncology2024

Feasibility of ctDNA in detecting minimal residual disease and predicting recurrence for colorectal cancer liver metastases.

Jennifer A Kalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.